IBRX261106C00006500
IBRX Nov 6 2026 6.50 Call
optionOPRA
InactiveOct 5, 2026
4.13USD+67.206%(+1.66)1Vol1OI
Loading…
Underlying
Underlying Price
$8.48
Type
Call
Strike
6.5
Expiration
Nov 6, 2026
DTE
17d
Moneyness
ITM
Intrinsic
$1.98
IBRX 6.5 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3d | — | — | 0 | 0 |
| Oct 30, 2026 | 10d | — | — | 0 | 0 |
| Nov 6, 2026 | 17d | $4.13 | +67.21% | 1 | 1 |
| Nov 13, 2026 | 24d | — | — | 0 | 0 |
| Nov 27, 2026 | 38d | — | — | 0 | 0 |
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.